Skip to main content
Log in

Burden and Distinctive Character of Allergic Bronchopulmonary Aspergillosis in India

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is an insidious pulmonary disorder caused by hypersensitivity reactions mounted against Aspergillus fumigatus. Usually, complicating the course of patients with asthma and cystic fibrosis, the affliction has recently been described in chronic obstructive pulmonary disease and pulmonary tuberculosis-related fibrocavitary disease. Patients commonly present with poorly controlled asthma, recurrent pulmonary infiltrates and bronchiectasis. More than six decades have elapsed since the first description of this entity; however, the condition remains poorly understood. The International Society for Human and Animal Mycology has formed a working group to address the deficiencies associated with understanding of this disorder. New criteria have been laid down for diagnosis and staging of the disorder, so as to simplify the identification and management of this condition. This review summarizes the recent advances that have taken place in this condition with special emphasis on the burden and distinct character of ABPA in the Indian subcontinent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135(3):805–26. doi:10.1378/chest.08-2586.

    Article  PubMed  Google Scholar 

  2. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–73. doi:10.1111/cea.12141.

    Article  CAS  PubMed  Google Scholar 

  3. Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis: a review and a report of eight new cases. Thorax. 1952;7(4):317–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Patterson R, Golbert TM. Hypersensitivity disease of the lung. Univ Mich Med Cent J. 1968;34:8–11.

    CAS  PubMed  Google Scholar 

  5. Shah JR. Allergic bronchopulmonary aspergillosis. J Assoc Physicians India. 1971;19:835–41.

    CAS  PubMed  Google Scholar 

  6. Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med. 2011;32(6):682–92. doi:10.1055/s-0031-1295716.

    Article  PubMed  Google Scholar 

  7. Agarwal R, Chakrabarti A. Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol. 2013;8(11):1463–74. doi:10.2217/fmb.13.116.

    Article  CAS  PubMed  Google Scholar 

  8. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(8):936–44.

    CAS  PubMed  Google Scholar 

  9. Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest. 2000;118(1):66–72.

    Article  CAS  PubMed  Google Scholar 

  10. Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol. 2000;18(4):181–5.

    CAS  PubMed  Google Scholar 

  11. Al-Mobeireek AF, El-Rab M, Al-Hedaithy SS, Alasali K, Al-Majed S, Joharjy I. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med. 2001;95(5):341–7.

    Article  CAS  PubMed  Google Scholar 

  12. Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest. 2005;127(4):1252–9. doi:10.1378/chest.127.4.1252.

    Article  PubMed  Google Scholar 

  13. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest. 2007;132(4):1183–90. doi:10.1378/chest.07-0808.

    Article  PubMed  Google Scholar 

  14. Prasad R, Garg R, Sanjay, Dixit RP. A study on prevalence of allergic bronchopulmonary aspergillosis in patients of bronchial asthma. Internet J Pulm Med. 2008;9(2).

  15. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, Chakrabarti A, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med. 2010;104(2):204–10.

    Article  PubMed  Google Scholar 

  16. Ghosh T, Dey A, Biswas D, Chatterjee S, Haldar N, Maiti PK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc. 2010;108(12):863–5.

    PubMed  Google Scholar 

  17. Sarkar A, Mukherjee A, Ghoshal AG, Kundu S, Mitra S. Occurrence of allergic bronchopulmonary mycosis in patients with asthma: an eastern India experience. Lung India. 2010;27(4):212–6. doi:10.4103/0970-2113.71949.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Ma YL, Zhang WB, Yu B, Chen YW, Mu S, Cui YL. Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(12):909–13.

    PubMed  Google Scholar 

  19. Agarwal R, Maskey D, Aggarwal AN, Saikia B, Garg M, Gupta D, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE. 2013;8(4):e61105. doi:10.1371/journal.pone.0061105.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Agarwal R, Chakrabarti A. Epidemiology of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, editor. Aspergillosis: from diagnosis to prevention. New York: Springer; 2010. p. 671–88.

    Google Scholar 

  21. Slavin RG, Stanczyk DJ, Lonigro AJ, Broun GO. Allergic bronchopulmonary aspergillosis—a North American Rarity. Clinical and immunologic characteristics. Am J Med. 1969;47(2):306–13.

    Article  CAS  PubMed  Google Scholar 

  22. Hoehne J, Reed C, Dickie H. Allergic bronchopulmonary aspergillosis is not rare. J Lab Clin Med. 1971;78(6):1007–8.

    CAS  PubMed  Google Scholar 

  23. Hoehne JH, Reed CE, Dickie HA. Allergic bronchopulmonary aspergillosis is not rare. with a note on preparation of antigen for immunologic tests. Chest. 1973;63(2):177–81.

    Article  CAS  PubMed  Google Scholar 

  24. Benatar SR, Keen GA, Du Toit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town. Clin Allergy. 1980;10(3):285–91.

    Article  CAS  PubMed  Google Scholar 

  25. Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985–88. Ir J Med Sci. 1991;160(9):288–90.

    Article  CAS  PubMed  Google Scholar 

  26. Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013;51(4):361–70. doi:10.3109/13693786.2012.738312.

    Article  PubMed  Google Scholar 

  27. Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53(2):138–43. doi:10.1111/j.1439-0507.2008.01680.x.

    Article  CAS  PubMed  Google Scholar 

  28. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86(4):405–14.

    Article  CAS  PubMed  Google Scholar 

  29. Agarwal R, Aggarwal AN, Gupta D, Bal A, Das A. Case report: a rare cause of miliary nodules—allergic bronchopulmonary aspergillosis. Br J Radiol. 2009;82(980):e151–4. doi:10.1259/bjr/20940804.

    Article  CAS  PubMed  Google Scholar 

  30. Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses. 2008;51(1):83–5. doi:10.1111/j.1439-0507.2007.01432.x.

    PubMed  Google Scholar 

  31. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol. 2010;48(7):988–94.

    Article  PubMed  Google Scholar 

  32. Mir E, Shah A. Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Prim Care Respir J. 2012;21(1):111–4. doi:10.4104/pcrj.2012.00001.

    Article  PubMed  Google Scholar 

  33. Chowdhary A, Agarwal K, Gaur S. A rare case of allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Indian J Allergy Asthma Immunol. 2012;26(1):20–4. doi:10.4103/0972-6691.104442.

    Article  Google Scholar 

  34. Bafadhel M, McKenna S, Agbetile J, Fairs A, Desai D, Mistry V, et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 2014;43(1):64–71. doi:10.1183/09031936.00162912.

    Article  PubMed  Google Scholar 

  35. Dhooria S, Kumar P, Saikia B, Aggarwal AN, Gupta D, Behera D, et al. Prevalence of Aspergillus sensitization in pulmonary tuberculosis-related fibrocavitary disease. Int J Tuberc Lung Dis. 2014;18(7):850–5. doi:10.5588/ijtld.13.0838.

  36. Agarwal R, Devi D, Gupta D, Chakrabarti A. A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis. Lung India. 2014; (in press).

  37. McCarthy DS, Pepys S. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 1. Clinical features. Clin Allergy. 1971;1(1):261–86.

    Article  Google Scholar 

  38. Shah A, Kala J, Sahay S, Panjabi C. Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol. 2008;101(4):363–9.

    Article  PubMed  Google Scholar 

  39. Agarwal R. Allergic bronchopulmonary aspergillosis: lessons learnt from genetics. Indian J Chest Dis Allied Sci. 2011;53(3):137–40.

    PubMed  Google Scholar 

  40. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2003;111(5):1001–7.

    Article  CAS  PubMed  Google Scholar 

  41. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol. 2006;143(3):414–9. doi:10.1111/j.1365-2249.2006.03007.x.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Agarwal R, Chakrabarti A. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, editor. Aspergillosis: from diagnosis to prevention. New York: Springer; 2010. p. 707–24.

    Google Scholar 

  43. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006;130(2):442–8. doi:10.1378/chest.130.2.442.

    Article  PubMed  Google Scholar 

  44. Agarwal R. Controversies in allergic bronchopulmonary aspergillosis. Int J Respir Care. 2010;6(2):53–4, 6–63.

  45. Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011;49(Suppl 1):S150–7. doi:10.3109/13693786.2010.504752.

    Article  PubMed  Google Scholar 

  46. Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Rep. 2011;11(5):403–13. doi:10.1007/s11882-011-0217-4.

    Article  CAS  PubMed  Google Scholar 

  47. Agarwal R, Vishwanath G, Aggarwal AN, Garg M, Gupta D, Chakrabarti A. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses. 2013;56(5):559–70. doi:10.1111/myc.12075.

    Article  CAS  PubMed  Google Scholar 

  48. Agarwal R, Khan A, Aggarwal AN, Varma N, Garg M, Saikia B, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J Infect Public Health. 2011;4(5–6):235–43. doi:10.1016/j.jiph.2011.08.006.

    Article  PubMed  Google Scholar 

  49. Agarwal R. Allergic bronchopulmonary aspergillosis. In: Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R, editors. Textbook of pulmonary and critical care medicine. 1st ed. New Delhi: Jaypee Publications; 2010. p. 947–70.

    Google Scholar 

  50. Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Pictorial essay: allergic bronchopulmonary aspergillosis. Indian J Radiol Imaging. 2011;21(4):242–52. doi:10.4103/0971-3026.90680.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4(4):141–50. doi:10.4329/wjr.v4.i4.141.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med. 2012;106(7):942–7. doi:10.1016/j.rmed.2012.03.001.

    Article  PubMed  Google Scholar 

  53. Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE. 2010;5(12):e15346. doi:10.1371/journal.pone.0015346.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Agarwal R. High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis. World J Radiol. 2010;2(1):41–3. doi:10.4329/wjr.v2.i1.41.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Agarwal R, Aggarwal AN, Gupta D. High-attenuation mucus in allergic bronchopulmonary aspergillosis: another cause of diffuse high-attenuation pulmonary abnormality. AJR Am J Roentgenol. 2006;186(3):904. doi:10.2214/AJR.05.0125.

    Article  PubMed  Google Scholar 

  56. Agarwal R, Aggarwal AN, Garg M, Saikia B, Gupta D, Chakrabarti A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia. 2012;174(3):193–201. doi:10.1007/s11046-012-9535-x.

    Article  PubMed  Google Scholar 

  57. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med. 1982;96(3):286–91.

    Article  CAS  PubMed  Google Scholar 

  58. Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(3):560–610. doi:10.1016/j.jaci.2013.04.007.

    Article  PubMed  Google Scholar 

  59. Agarwal R, Aggarwal AN, Garg M, Saikia B, Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses. 2014; (in press).

  60. Agarwal R, Chakrabarti A. Allergic bronchopulmonary aspergillosis. In: Chakrabarti A, editor. Fungal infections in Asia: the eastern frontier of mycology. New Delhi: Elsevier; 2013. p. 173–93.

    Google Scholar 

  61. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110(5):685–92.

    Article  PubMed  Google Scholar 

  62. Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 2012;33(2):265–81. doi:10.1016/j.ccm.2012.02.003.

    Article  PubMed  Google Scholar 

  63. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342(11):756–62.

    Article  CAS  PubMed  Google Scholar 

  64. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111(5):952–7.

    Article  CAS  PubMed  Google Scholar 

  65. Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162–76. doi:10.1093/jac/dkt508.

    Article  CAS  PubMed  Google Scholar 

  66. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009;15(7):1068–76. doi:10.3201/eid1507.090043.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Denning DW, Perlin DS. Azole resistance in Aspergillus: a growing public health menace. Future Microbiol. 2011;6(11):1229–32.

    Article  CAS  PubMed  Google Scholar 

  68. Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, et al. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol. 2001;51(5):443–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J. Inhaled budesonide induced Cushing’s syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros. 2003;2(2):72–5. doi:10.1016/S1569-1993(03)00022-5.

    Article  PubMed  Google Scholar 

  70. Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012;49(4):423–33. doi:10.3109/02770903.2012.662568.

    Article  CAS  PubMed  Google Scholar 

  71. Agarwal R. What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Expert Rev Respir Med. 2012;6(4):363–71. doi:10.1586/ers.12.35.

    Article  CAS  PubMed  Google Scholar 

  72. Sehgal IS, Agarwal R. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis. J Postgrad Med. 2014;60(1):41–5. doi:10.4103/0022-3859.128806.

    Article  CAS  PubMed  Google Scholar 

  73. Singh Sehgal I, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations. Eur Respir Rev. 2014;23(131):149–52. doi:10.1183/09059180.00004813.

    Article  PubMed  Google Scholar 

  74. Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E. Omalizumab, an anti-immunoglobulin E antibody: state of the art. Drug Des Devel Ther. 2014;8:197–207. doi:10.2147/dddt.s49409.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ritesh Agarwal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarwal, R. Burden and Distinctive Character of Allergic Bronchopulmonary Aspergillosis in India. Mycopathologia 178, 447–456 (2014). https://doi.org/10.1007/s11046-014-9767-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-014-9767-z

Keywords

Navigation